TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Proximity Alarms to Reduce Patient Falls
Brief Summary: The purpose of this study is to test an intervention to introduce and implement proximity alarms on the risk of falls in hospitalized patients.


Options:
A: Intervention Type: DEVICE; Name: BedEx Patient Occupancy Monitoring System; Assigned to Arm(s): N/A
B: Arm Label: Whole Body Vibration Group; Type: EXPERIMENTAL; Interventions: Device: Vibrosphère device | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Vibrosphère device; Assigned to Arm(s): Whole Body Vibration Group
C: Arm Label: Fall QI; Type: EXPERIMENTAL; Interventions: Behavioral: Falls QI | Arm Label: Connect & Falls QI; Type: EXPERIMENTAL; Interventions: Behavioral: Connect | Intervention Type: BEHAVIORAL; Name: Falls QI; Assigned to Arm(s): Fall QI | Intervention Type: BEHAVIORAL; Name: Connect; Assigned to Arm(s): Connect & Falls QI
D: Arm Label: LTC Osteoporosis Toolkit Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educ sessions & LTC Osteoporosis toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Educ sessions & LTC Osteoporosis toolkit | Intervention Type: OTHER; Name: Educ sessions & LTC Osteoporosis toolkit; Assigned to Arm(s): Educ sessions & LTC Osteoporosis toolkit

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospital-based Brief Intervention for Alcohol Problems
Brief Summary: The objective of this project was to test whether screening and brief intervention for unhealthy alcohol use leads to improved alcohol-related outcomes (such as alcohol consumption and linkage to alcohol assistance) and is cost-effective.


Options:
A: Arm Label: Standard Positive Prevention Counselling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational intervention counselling plus SPP | Arm Label: Alcohol Motivational intervention counselling plus SPP; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational intervention counselling plus SPP | Intervention Type: BEHAVIORAL; Name: Motivational intervention counselling plus SPP; Assigned to Arm(s): Alcohol Motivational intervention counselling plus SPP, Standard Positive Prevention Counselling
B: Arm Label: 1) assessment plus motivational interview; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: motivational interviewing | Intervention Type: BEHAVIORAL; Name: motivational interviewing; Assigned to Arm(s): 1) assessment plus motivational interview
C: Intervention Type: BEHAVIORAL; Name: Brief Intervention (adaptation of motivational interviewing); Assigned to Arm(s): N/A
D: Arm Label: EARLY; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing plus feedback | Arm Label: Video Information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Video | Arm Label: Informational Brochure; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Informational Brochure | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing plus feedback; Assigned to Arm(s): EARLY | Intervention Type: BEHAVIORAL; Name: Video; Assigned to Arm(s): Video Information | Intervention Type: BEHAVIORAL; Name: Informational Brochure; Assigned to Arm(s): Informational Brochure

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hospital-based Brief Intervention for Alcohol Problems
Brief Summary: The objective of this project was to test whether screening and brief intervention for unhealthy alcohol use leads to improved alcohol-related outcomes (such as alcohol consumption and linkage to alcohol assistance) and is cost-effective.


Options:
A: Intervention Type: BEHAVIORAL; Name: Brief Intervention (adaptation of motivational interviewing); Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adapted Motivational Interviewing & Skills Training | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adapted Motivational Interviewing & Skills Training | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Adapted Motivational Interviewing & Skills Training; Assigned to Arm(s): 1, 2
C: Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MI; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): MI
D: Arm Label: 1) assessment plus motivational interview; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: motivational interviewing | Intervention Type: BEHAVIORAL; Name: motivational interviewing; Assigned to Arm(s): 1) assessment plus motivational interview

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Gabapentin as an Adjunct to Naltrexone for Alcoholism
Brief Summary: The purpose of this study is to determine whether, after a period of abstinence, adding 6 weeks of gabapentin (a medication approved to treat seizures) to a standard 16-week naltrexone (an opiate blocking agent approved for the treatment of alcohol dependence) treatment protocol is helpful in decreasing relapse to drinking compared to naltrexone alone or placebo. All participants will receive alcohol counseling.


Options:
A: Intervention Type: DRUG; Name: naltrexone (Revia); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: acamprosate (Campral); Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: topiramate; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naltrexone | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naltrexone plus Gabapentin | Arm Label: 3; Type: SHAM_COMPARATOR; Interventions: Other: Inactive Placebo | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Naltrexone plus Gabapentin; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: Inactive Placebo; Assigned to Arm(s): 3
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Drug: Levetiracetam (Keppra), Drug: Placebo | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: Levetiracetam (Keppra), Drug: Placebo | Intervention Type: DRUG; Name: Levetiracetam (Keppra); Assigned to Arm(s): Group A, Group B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group A, Group B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Short-term Versus Long-term Treatment in Generalized Anxiety Disorder
Brief Summary: This study will assess the effectiveness of venlafaxine XR, randomized to either venlafaxine XR or placebo in preventing the relapse of generalized anxiety disorder after 6 months of treatment versus 12 months of treatment.


Options:
A: Arm Label: Cognitive therapy plus medications; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Therapy, Drug: Medications | Arm Label: Medications alone; Type: EXPERIMENTAL; Interventions: Drug: Medications | Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): Cognitive therapy plus medications | Intervention Type: DRUG; Name: Medications; Assigned to Arm(s): Cognitive therapy plus medications, Medications alone
B: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Risperidone, Drug: Escitalopram, Drug: Citalopram, Drug: Sertraline, Drug: Paroxetine | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Paroxetine; Assigned to Arm(s): A
C: Arm Label: Supported Protocolized Discontinuation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supported Protocolized Discontinuation (SPD) | Arm Label: SPD + Mindfulness (MBCT); Type: EXPERIMENTAL; Interventions: Behavioral: Supported Protocolized Discontinuation (SPD), Behavioral: Mindfulness Based Cognitive Therapy (MBCT) | Intervention Type: BEHAVIORAL; Name: Supported Protocolized Discontinuation (SPD); Assigned to Arm(s): SPD + Mindfulness (MBCT), Supported Protocolized Discontinuation | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Cognitive Therapy (MBCT); Assigned to Arm(s): SPD + Mindfulness (MBCT)
D: Arm Label: Open-Label Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Drug Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Double-Blind Drug-After-Drug Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR | Arm Label: Double-Blind Placebo-After-Drug Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Double-Blind Placebo-After-Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Venlafaxine XR; Assigned to Arm(s): Double-Blind Drug Group, Double-Blind Drug-After-Drug Group, Open-Label Group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Double-Blind Placebo Group, Double-Blind Placebo-After-Drug Group, Double-Blind Placebo-After-Placebo Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Primary Care in Patients With Mental Disorders
Brief Summary: This study will determine the effectiveness of medical case management in improving the medical care of people with mental disorders or substance abuse problems.


Options:
A: Arm Label: CBT preference arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive-behavioral therapy | Arm Label: Yoga preference arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga | Arm Label: CBT randomized arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive-behavioral therapy | Arm Label: Yoga randomized arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral therapy; Assigned to Arm(s): CBT preference arm, CBT randomized arm | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): Yoga preference arm, Yoga randomized arm
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Driving in Mild Dementia Decision Tool | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Driving in Mild Dementia Decision Tool; Assigned to Arm(s): Intervention
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: A web based-Patient Decision Aid (PtDA) (shown on the computer) | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: A web-based fact sheet (one page shown on the computer) with general information on mental health as a part of usual care. | Intervention Type: OTHER; Name: A web based-Patient Decision Aid (PtDA) (shown on the computer); Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: A web-based fact sheet (one page shown on the computer) with general information on mental health as a part of usual care.; Assigned to Arm(s): Control group
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse case management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Nurse case management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Primary Care in Patients With Mental Disorders
Brief Summary: This study will determine the effectiveness of medical case management in improving the medical care of people with mental disorders or substance abuse problems.


Options:
A: Arm Label: TEAMcare treatment of diabetes; Type: ACTIVE_COMPARATOR; Interventions: Other: TEAMcare treatment of diabetes | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: TEAMcare treatment of diabetes; Assigned to Arm(s): TEAMcare treatment of diabetes
B: Arm Label: Computerized CBT + Internet Support Group; Type: EXPERIMENTAL; Interventions: Behavioral: CCBT+ISG/Collaborative Care | Arm Label: Computerized CBT Alone; Type: EXPERIMENTAL; Interventions: Behavioral: CCBT/Collaborative Care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CCBT+ISG/Collaborative Care; Assigned to Arm(s): Computerized CBT + Internet Support Group | Intervention Type: BEHAVIORAL; Name: CCBT/Collaborative Care; Assigned to Arm(s): Computerized CBT Alone
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse case management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Nurse case management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): 2
D: Arm Label: IMPACT; Type: EXPERIMENTAL; Interventions: Other: IMPACT | Arm Label: Care as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: IMPACT; Assigned to Arm(s): IMPACT

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treating PTSD in Children Exposed to Domestic Violence
Brief Summary: This study will determine whether trauma-focused cognitive behavioral therapy (TF-CBT) is more effective than child-centered therapy (CCT) in reducing post traumatic stress disorder (PTSD) in children exposed to domestic violence (DV).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma-focused cognitive behavioral therapy (TF-CBT) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Child-centered supportive therapy (CCT) | Intervention Type: BEHAVIORAL; Name: Trauma-focused cognitive behavioral therapy (TF-CBT); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Child-centered supportive therapy (CCT); Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Risk Reduction through Family Therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Risk Reduction through Family Therapy | Intervention Type: BEHAVIORAL; Name: Risk Reduction through Family Therapy; Assigned to Arm(s): 1, 2
C: Arm Label: TF-CBT; Type: EXPERIMENTAL; Interventions: Behavioral: TF-CBT | Arm Label: Waiting List control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: TF-CBT; Assigned to Arm(s): TF-CBT
D: Arm Label: Waitlist+EducAid; Type: ACTIVE_COMPARATOR; Interventions: Other: EducAid educational programming | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: YRI only; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Arm Label: YRI+EducAid; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Intervention Type: BEHAVIORAL; Name: YRI; Assigned to Arm(s): YRI only, YRI+EducAid | Intervention Type: OTHER; Name: EducAid educational programming; Assigned to Arm(s): Waitlist+EducAid, YRI only, YRI+EducAid

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-controlled Trial of Fluoxetine in Preschool Children
Brief Summary: This study is a pilot study to evaluate the feasibility and safety of conducting a year long, double-blind, placebo-controlled trial of fluoxetine in pre-school children to enhance developmental processes in core areas impacted by autism.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Cannabinoids - 99% pure cannabinoids mix; Type: EXPERIMENTAL; Interventions: Drug: Cannabinoids - 99% pure cannabinoids mix | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Cannabinoids - whole plant extract; Type: EXPERIMENTAL; Interventions: Drug: Cannabinoids - whole plant extract | Intervention Type: DRUG; Name: Cannabinoids - 99% pure cannabinoids mix; Assigned to Arm(s): Cannabinoids - 99% pure cannabinoids mix | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Cannabinoids - whole plant extract; Assigned to Arm(s): Cannabinoids - whole plant extract
C: Arm Label: Riluzole; Type: EXPERIMENTAL; Interventions: Drug: Riluzole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: Riluzole; Assigned to Arm(s): Riluzole | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Placebo
D: Arm Label: Arbaclofen; Type: EXPERIMENTAL; Interventions: Drug: Arbaclofen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Arbaclofen; Assigned to Arm(s): Arbaclofen | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-controlled Trial of Fluoxetine in Preschool Children
Brief Summary: This study is a pilot study to evaluate the feasibility and safety of conducting a year long, double-blind, placebo-controlled trial of fluoxetine in pre-school children to enhance developmental processes in core areas impacted by autism.


Options:
A: Arm Label: Transdermal nicotine first, placebo last; Type: EXPERIMENTAL; Interventions: Drug: Transdermal nicotine, Other: Transdermal placebo | Arm Label: Transdermal placebo first, nicotine last; Type: EXPERIMENTAL; Interventions: Drug: Transdermal nicotine, Other: Transdermal placebo | Intervention Type: DRUG; Name: Transdermal nicotine; Assigned to Arm(s): Transdermal nicotine first, placebo last, Transdermal placebo first, nicotine last | Intervention Type: OTHER; Name: Transdermal placebo; Assigned to Arm(s): Transdermal nicotine first, placebo last, Transdermal placebo first, nicotine last
B: Arm Label: D-cycloserine; Type: EXPERIMENTAL; Interventions: Drug: D-cycloserine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: D-cycloserine; Assigned to Arm(s): D-cycloserine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Vasopressin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vasopressin | Intervention Type: DRUG; Name: Vasopressin; Assigned to Arm(s): Vasopressin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-controlled Trial of Fluoxetine in Preschool Children
Brief Summary: This study is a pilot study to evaluate the feasibility and safety of conducting a year long, double-blind, placebo-controlled trial of fluoxetine in pre-school children to enhance developmental processes in core areas impacted by autism.


Options:
A: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: Risperidone low dose | Arm Label: 002; Type: EXPERIMENTAL; Interventions: Drug: Risperidone high dose | Arm Label: 003; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 003 | Intervention Type: DRUG; Name: Risperidone high dose; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: Risperidone low dose; Assigned to Arm(s): 001
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Memantine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Memantine Hydrochloride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Memantine Hydrochloride; Assigned to Arm(s): Memantine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo for AChEI and Choline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Indistinguishable placebo tablets, matching both donepezil and choline | Arm Label: AChEI and Choline; Type: EXPERIMENTAL; Interventions: Drug: Acetyl-Choline Esterase Inhibitors and Choline supplements | Intervention Type: DRUG; Name: Acetyl-Choline Esterase Inhibitors and Choline supplements; Assigned to Arm(s): AChEI and Choline | Intervention Type: DRUG; Name: Indistinguishable placebo tablets, matching both donepezil and choline; Assigned to Arm(s): Placebo for AChEI and Choline

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Depression Prevention Program for High-Risk Adolescents
Brief Summary: This study will compare the effectiveness of two programs designed to prevent depression in adolescents.


Options:
A: Arm Label: Mood monitoring; Type: EXPERIMENTAL; Interventions: Device: Mobile Tracking Young People's Experiences (mobiletype) | Arm Label: Comparison monitoring program; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Mobile Tracking Young People's Experiences (mobiletype); Assigned to Arm(s): Mood monitoring
B: Arm Label: Mindfulness-based stress reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based stress reduction | Arm Label: Healthy Topics; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Mindfulness-based stress reduction | Intervention Type: BEHAVIORAL; Name: Mindfulness-based stress reduction; Assigned to Arm(s): Healthy Topics, Mindfulness-based stress reduction
C: Arm Label: Prevention programme; Type: EXPERIMENTAL; Interventions: Behavioral: Prevention programme | Arm Label: Control (treatment as usual); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Prevention programme; Assigned to Arm(s): Prevention programme
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavior therapy (CBT) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supportive/expressive (S/E) therapy | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Bibliotherapy | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive behavior therapy (CBT); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Supportive/expressive (S/E) therapy; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Bibliotherapy; Assigned to Arm(s): 3

Answer: D